OneSource

About:

OneSource is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets.

Website: https://www.onesourcecdmo.com/

Twitter/X: StelisBiopharma

Top Investors: TPG Growth, Think Investments, RouteOne, Strides Pharma Science, GMS Holdings

Description:

OneSource is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing, and filling/finishing of proteins and peptides. Offer services at every stage of the development life cycle, from pre-clinical and clinical development to commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO services our deep commitment to quality, service, and compliance.

Total Funding Amount:

$230M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bangalore, Karnataka, India

Founded Date:

2013-01-01

Contact Email:

info(AT)stelis.com

Founders:

Arun Kumar

Number of Employees:

251-500

Last Funding Date:

2021-03-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai